Torrent Pharma’s Share Price Peaks at 52-Week High of Rs 2,745.55 on March 6 Following Successful US FDA Inspection.
At 09:38 am, Torrent Pharmaceuticals’ stock was trading at Rs 2,700.00 on the BSE, marking an increase of Rs 37.80 or 1.42 percent.
The US Food and Drug Administration (USFDA) has issued an establishment inspection report (EIR) for the company’s manufacturing facility in Gujarat, indicating the successful conclusion of the inspection by the regulator.
The inspection, conducted as a pre-approval inspection (PAI), took place at the company’s oral-oncology manufacturing facility in Bileshwarpura, Gujarat, spanning from December 5, 2023, to December 11, 2023.
In the quarter ending December 2023, the company recorded a significant 56.5 percent increase in its net profit, reaching Rs 443 crore.
Over the past year, the company’s share price has surged by an impressive 80 percent.
Disclaimer: The opinions and investment tips provided by investment experts are their own and do not necessarily reflect the views of the website or its management. Bystox.in recommends users to consult certified experts before making any investment decisions.